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CEACAM1 promotes insulin extraction, an event that occurs mainly in liver. Pheno-
copying global Ceacam1 null mice (Cc1–/–), C57/BL6J mice fed a high-fat (HF) diet
exhibited reduced hepatic CEACAM1 levels and impaired insulin clearance, followed
by hyperinsulinemia, insulin resistance, and visceral obesity. Conversely, forced liver-
specific expression of CEACAM1 protected insulin sensitivity and energy expenditure,
and limited gain in total fat mass by HF diet in L-CC1 mice. Because CEACAM1 protein
is barely detectable in white adipose tissue (WAT), we herein investigated whether hepatic
CEACAM1-dependent insulin clearance pathways regulate adipose tissue biology in
response to dietary fat. While HF diet caused a similar body weight gain in L-CC1,
this effect was delayed and less intense relative to wild-type (WT) mice. Histological
examination revealed less expansion of adipocytes in L-CC1 than WT by HF intake.
Immunofluorescence analysis demonstrated a more limited recruitment of crown-like
structures, and qRT-PCR analysis showed no significant rise in TNFα mRNA levels in
response to HF intake in L-CC1 than WT mice. Unlike WT, HF diet did not activate TGF-β
in WAT of L-CC1 mice, as assessed by Western analysis of Smad2/3 phosphorylation.
Consistently, HF diet caused relatively less collagen deposition in L-CC1 than WT mice,
as shown by Trichrome staining. Coupled with reduced lipid redistribution from liver
to visceral fat, lower inflammation and fibrosis could contribute to protected energy
expenditure against HF diet in L-CC1 mice. The data underscore the important role of
hepatic insulin clearance in the regulation of adipose tissue inflammation and fibrosis.
Keywords: insulin clearance, liver-adipose tissue axis, insulin resistance, steatosis, CEACAM1, fibrosis,
inflammation
Abbreviations: α-Sma, alpha-smooth muscle actin; ApoB48/ApoB100, apolipoprotein B; Col6α3; alpha 3 chain of collagen 6-
also known as endotrophin; Cc1–/–, global Ceacam1 null mouse; CEACAM1, carcinoembryonic antigen-related cell adhesion
molecule 1; Ceacam1, gene encoding CEACAM1 protein; Fasn, fatty acid synthase; FAT/CD36, fatty acid translocase/cluster of
differentiation protein 36; FATP, fatty acid transporter protein; HF, high-calorie high-fat diet; Hsl, hormone-sensitive lipase; L-
CC1, mice with liver-specific over-expression of wild-type CEACAM1; Lpl, lipoprotein lipase; L-SACC1, liver-specific S503A
CEACAM1 mutant mouse; NEFA, non-esterified fatty acids; RD, regular diet; SREBP-1c, sterol regulatory element-binding
protein; TNFα, tumor necrosis factor alpha; TGF-β transforming growth factor beta.
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Introduction
Carcinoembryonic antigen-related cell adhesion molecule 1
(CEACAM1) promotes insulin extraction in liver to regulate
insulin action. This finding is bolstered by the observation that
mice with liver-specific inactivation of CEACAM1 (L-SACC1)
or with global null deletion of Ceacam1 gene (Cc1–/–) manifest
hyperinsulinemia secondary to impaired insulin clearance. This
causes insulin resistance in addition to hepatic steatosis (1–3). The
latter is mediated by the transcriptional activation of lipogenic
genes by sterol regulatory element-binding protein (SREBP-1c)
in response to chronically elevated levels of insulin (4). It can
also be caused by blunted CEACAM1-mediated downregulation
of fatty acid synthase (Fasn) activity under hyperinsulinemic
conditions (5).
Both L-SACC1 and Cc1 /  mutant mice also display vis-
ceral obesity (1–3). Contributing to this metabolic anomaly, is
increased redistribution of hepatic triacylglycerol to white adi-
pose tissue (WAT), in particular that mice are propagated on
the C57/BL6J genetic background, which favors redistribution to
adipose tissue (6).
We have recently shown that high-fat (HF) intake causes insulin
resistance in part by reducing CEACAM1 mRNA and protein
levels in liver (7). Conversely, transgenically protecting hepatic
CEACAM1 in L-CC1 mice prevented diet-induced insulin resis-
tance and limited hepatic steatosis in response to HF diet (7).
Additionally, it blunted the negative effect of HF diet on energy
expenditure and spontaneous locomotor activity. This protective
effect of hepatic CEACAM1 gain-of-function could be mediated,
at least in part, by inducing FGF21, which in turn, enhances fatty
acid oxidation in liver (8, 9) and increases brown adipogene-
sis (10, 11).
L-CC1 transgenic mice with liver-specific gain-of-function
also accumulated less total fat mass than their wild-type (WT)
counterparts in response to 4months of HF intake (7). Because
CEACAM1 is barely detectable at the protein level in adipose
tissue (12), we hypothesized that extra-adipocytic factors brought
about by overexpressing CEACAM1 in liver are involved. To
test this hypothesis, we investigated whether altered CEACAM1-
dependent insulin clearance pathways regulate adipose tissue
biology in response to HF diet.
Materials and Methods
Mice Generation
As recently described (7), L-CC1 transgenic mice with liver-
specific over-expression of FLAG-tagged WT rat CEACAM1
were generated using human apolipoprotein A1 (APOA1) pro-
moter/enhancer element (13), and propagated on the C57/BL6J
background (Jackson Laboratories), as described (7). The “mini-
gene” construct was obtained by subcloning the proximal APOA1
promoter 50 of a Ceacam1 rat minigene-containing intron 1 into
pCMV-3Tag-3A plasmid at Not1 site.
Starting at 2months of age,malemice were fed ad libitum either
a standard diet (12:66:22% calories from fat:carbohydrate:protein)
or a HF diet (45:35:20% calories from fat:carbohydrate:protein)
(Catalog #D12451, Research Diets). Mice were kept in a
12-h-dark/light cycle. This study was carried out in accordance
with the recommendations of the Institutional Animal Care and
Utilization Committee (IACUC), which approved all procedures.
Metabolic Parameters
Mice were fasted overnight and their retro-orbital venous blood
drawn at 11:00 hours the following day. Plasma was stored at
 80°C until levels of insulin (Linco Research), FFA (NEFA C,
Wako), and triacylglycerol (Pointe Scientific Triglyceride, Can-
ton) were assessed. Hepatic triacylglycerol content was measured
as previously described (1, 3).
Body Composition
Whole body composition was assessed by nuclear magnetic reso-
nance (NMR; Bruker Optics).
Immunofluorescence of Visceral White
Adipose Tissue
Visceral WAT was formalin-fixed, cut into 2–3mm sections,
and transferred to Dulbecco’s phosphate buffered saline (PBS,
Sigma Aldrich) for 48 h at 4°C. Adipose tissue was permeabilized
in 1% Triton X-100 (Fisher) in PBS for 10min before being
stained with rat anti-mouse F4/80 (Invitrogen, Carlsbad) to mark
macrophages and detected with donkey anti-rat IgG conjugated to
Alexa Fluor488 (Invitrogen). Tissues were incubated with primary
antibodies overnight at room temperature (RT) in the dark and
washed 3 with staining buffer before being subjected to sec-
ondary stain for 2 h and wash (3) in PBS. Stained samples were
then counterstained for 15min at RTwith 5µMBODIPY 558/568
(Molecular Probes, Inc.) to visualize lipid. Adipose tissue samples
were placed directly on a coverslip with buffer and visualized.
Laser-Scanning Confocal Microscopy
Sampleswere imaged using a LeicaTCS SP5 laser-scanningmicro-
scope (Leica Microsystems) equipped with conventional solid
state and a Ti-sapphire tunable multi-photon laser (Coherent).
Images were acquired in the 3D XYZ plane in 2.5µm steps with a
20 objective (NA 0.70) using the sequential scan mode to elimi-
nate any spectral overlap in the individual fluorophores. Specif-
ically, AlexaFluor488 (Invitrogen) was excited at 488 nm with
collection at 500–558 nm. The BODIPY 558/568 dye (Molecular
Probes, Inc.) was excited at 561 nm and collected at 567–609 nm.
Selected images are a 2D representation of the 3D laser-scanning
confocal microscopy (LSCM) image z-stack, as labeled.
Gomori’s Trichrome Staining
Adipose tissue (n= 5 permouse group) was fixed in 10% formalin
and replaced by 70% ethanol before undergoing blocking in paraf-
fin. Sections were deparaffinized at 60°C and hydrated in deion-
ized water. Antigens were unmasked in Bouin’s Fluid at 56°C for
45min. Upon rinsing in deionized water, nuclei were stained with
WorkingWeigert’s Iron Hematoxylin at RT for 10min. Trichrome
stain was performed using the Thermo Scientific Richard-Allan
Scientific Chromaview-advanced Testing (Cat. No. 87020). In
brief, rinsed slides were trichrome stained at RT for 15min and
dehydrated sequentially in 1% acetic acid solution for 1min, 95%
ethanol for 30 s, and 100% ethanol for 1min (twice). Sections were
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then cleared in three changes of clearing reagent for 1min each
and mounted.
Western Analysis
Tissues were lysed and proteins analyzed by SDS-PAGE fol-
lowed by immunoprobing with polyclonal antibodies against
Fasn (α-Fasn) (Assay Designs), fatty acid translocase/cluster of
differentiation protein 36 (FAT/CD36) (Santa Cruz Biotechnol-
ogy), apolipoprotein B (Chemicon International), and total and
phospho-Smad 2 and Smad 3 (Cell Signaling). For normalization,
monoclonal antibodies against α-actin (Santa Cruz) were used.
Blots were incubated with horseradish peroxidase-conjugated
anti-goat IgG (Santa Cruz Biotechnology), anti-mouse or anti-
rabbit IgG (Amersham) antibodies, and proteins detected by
enhanced chemiluminescence (ECL; Amersham) prior to quan-
tification by densitometry (Image J software).
Semi-Quantitative Real-Time RT-PCR
Total hepatic RNA was isolated with PerfectPure RNA Tissue
Kit (50), and total adipose tissue RNA was isolated with RNeasy
Lipid Tissue Mini Kit (Qiagen) according to the manufacturer’s
protocol. cDNA was synthesized by ImProm-II™ Reverse Tran-
scriptase (Promega), using 1µg of total RNA and oligo dT primers
(Table 1). cDNA was evaluated with real-time quantitative PCR
(Step One Plus, Applied Biosystems). The relative amounts of
mRNAwere calculated by comparison to the corresponding stan-
dards and normalized relative to 18S.
Statistical Analysis
Data were analyzed with SPSS software by two-way analysis of
variance (ANOVA) or two-tailed Student’s t-test with GraphPad
Prism 4 software. P< 0.05 was statistically significant.
Results
Lipid Metabolism
As expected, HF diet caused hyperinsulinemia and fed hyper-
glycemia (Table 2), markers of insulin resistance, in WT mice.
In support of the positive effect of hyperinsulinemia on lipo-
genesis (4), qRT-PCR (Table 3) and Western blot analysis
showed increased mRNA and protein levels of Fasn, respec-
tively, in the liver of HF-fed WT mice relative to mice fed a
regular diet (RD) (Figure 1A). HF diet also induced hepatic
mRNA (Table 3) and protein levels of CD36 fatty acid translo-
case (Figure 1A), in addition to inducing the mRNA level of
fatty acid transport protein-1 (Fatp-1) (Table 3). Together with
increased lipogenesis, elevated lipid transport could contribute
to increased hepatic triacylglycerol content in HF-fed WT mice
(Table 2).
Increased production of hepatic triacylglycerol drives
output, as supported by elevated plasma apolipoprotein B
(ApoB48/ApoB100) protein levels in WT mice (Figure 1B).
With fasting plasma triacylglycerol levels being intact (Table 2),
it is likely that triacylglycerol was redistributed to the WAT, as
expected from mice on the C57/BL6J genetic background that
favors substrates partitioning to the adipose tissue (6). Supporting
this notion, mRNA levels of Fatp-4 and lipoprotein lipase (Lpl)
TABLE 1 | Real-time PCR primer sequences from mouse genes.
Primer Forward sequence (50–30) Reverse sequence (50–30)
Cd36 TCTTGGCTACAGCAAGGCC
AGATA
AGCTATGCATGGAACATGACG
Fatp-1 TCACTGGCGCTGCTTTGGTT GGACGTGGCTGTGTATGG
Fatp-4 GTGAGATGGCCTCAGCTATC GAAGAGGGTCCAGATGCTCT
Lpl AAGGTCAGAGCCAAGAGAA
GCA
CCAGAAAAGTGAATCTTGACT
TGGT
Srebp-1c GGAGCCATGGATTGCACATT GCTTCCAGAGAGGAGGCCA
Hsl GGCTTACTGGGCACAGATACCT CTGAAGGCTCTGAGTTGCTCAA
F4/80 CAAGGAGGACAGAGTTTATCGTG CTTTGGCTATGGGCTTCCAGTC
TNFα CCACCACGCTCTTCTGTCTAC AGGGTCTGGGCCATAGAACT
Smad7 GTTGCTGTGAATCTTACGGG ATCTGGACAGCCTGCA
Col6α3 ACCTAGAGAACGTTACCTCACT GTCAGCTGAGTCTTGTGCTGT
α-Sma CGTGGCTATTCCTTCGTTAC TGCCAGCAGACTCCATCC
18S TTCGAACGTCTGCCCTATCAA ATGGTAGGCACGGCGACTA
that are critical in lipid transport to the adipocyte were elevated
in HF-fed relative to RD-fed WT mice (Table 4). This appears to
drive adipogenesis, as suggested by higher Srebp-1c mRNA levels
(Table 4), and ultimately, increased visceral obesity (Table 2).
Elevated mRNA levels of hormone sensitive lipase (Hsl) (Table 4)
and the rise in fasting plasma NEFA levels (Table 2) are consistent
with increased lipolysis in HF-fed WT mice.
In L-CC1 mice, however, hepatic triacylglycerol content was
neither modified by HF intake (Table 2) nor were mRNA levels
of Fasn, Fatp-1, and Cd36 (Table 3). Consistent with normal
hepatic lipogenesis, plasma ApoB48/ApoB100 protein levels in L-
CC1 mice were not significantly altered by HF diet (Figure 1B).
Moreover, HF did notmodulate themRNA level of genes involved
in lipid metabolism in the adipocyte (Lpl, Fatp-4, and Srebp-1c)
(Table 4). Consistent with normal fasting plasmaNEFA (Table 2),
HF did not alter Hsl mRNA levels in the WAT of L-CC1, as it did
to WT mice (Table 4).
Visceral Obesity
High-fat feeding time dependently increased body weight gain
in WT mice (Figure 2A). In contrast, it took 6weeks before
HF induced a statistically significant body weight gain in L-
CC1 (Figure 2A). NMR analysis (Figure 2B) revealed persistently
lower fatmass in L-CC1 relative toWTmice under normal feeding
conditions until ~5months of age, at which point this difference
became statistically insignificant (Figure 2B, starting at about
11weeks of experimental feeding). In contrast to total fat mass,
visceral (mostly gonadal) and subcutaneous fat mass remained
lower inRD-fedL-CC1 thanRD-fedWTmice evenuntil 6months
of age (Table 2).
While HF feeding caused an increase in total fat mass relative
to RD feeding in both mouse groups, this effect was delayed (at
5 vs. 3 weeks in L-CC1 vs. WT) (Figure 2B). Furthermore, fat
accumulation in L-CC1 mice did not become significantly higher
than RD-fed WT until after 7weeks of HF feeding but remained
lower than HF-fed WT even after 4months of HF, as shown by
NMR (Figure 2B), and by 1H-magnetic resonance spectroscopy
(7). After 4months of HF diet, visceral fat mass remained lower
in L-CC1 than WT mice, while subcutaneous fat mass became
comparable in both groups of mice (Table 2).
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TABLE 2 | Effect of high-fat diet for 4months on plasma and tissue biochemistry.
WT L-CC1
RD HF RD HF
Body weight (BW) (g) 26:0 0:80 34:0 1:12* 24:0 1:03 34:0 2:32*
Body length (cm) 9:73 1:52 10:5 2:21 9:70 1:00 10:4 1:77
Visceral adipose tissue (% BW) 2:45 0:25 7:55 0:26* 1:36 0:26† 5:76 0:48*†
Brown adipose tissue (% BW) 0:39 0:05 0:39 0:03 0:34 0:03 0:36 0:04
Subcutaneous fat (% BW) 1:76 0:12 6:23 0:51* 1:18 0:13† 5:02 0:65*
Fasting plasma insulin (pM) 60:0 1:43 162:0 8:15* 58:2 2:14 78:3 3:34*†
Fed blood glucose (mg/dl) 120:0 1:42 150:0 3:52* 124:0 3:25 130:0 2:82†
Hepatic triacylglycerol (µg/mg protein) 122:0 5:00 505:0 20:4* 135:0 3:40 152:0 14:0†
Fasting plasma triacylglycerol (mg/dl) 65:4 3:82 75:3 4:60 50:3 3:22† 58:4 1:42†
Fasting plasma NEFA (mEq/l) 0:62 0:04 0:92 0:03* 0:58 0:02 0:64 0:04†
Mice (n>8/feeding group/genotype) were fed an HF diet for 4months starting at 2months of age. Fat depots were excised and weighed. Intra-abdominal visceral adipose tissue fat
refers to combined weight of mesenteric and gonadal fat. The relative mass of fat depots was expressed as percentage of body weight (% BW).
Values are expressed as meanSEM.
*P<0.05 HF vs. RD per genotype.
†P<0.05 L-CC1 vs. WT per feeding group.
TABLE 3 | Effect of high-fat diet on mRNA levels of lipid metabolism genes
in liver.
WT L-CC1
RD HF RD HF
Fasn 1:25 0:12 3:60 0:40* 1:00 0:20 1:45 0:25†
Cd36 1:23 0:11 2:00 0:30* 0:67 0:12 0:86 0:12†
Fatp-1 1:19 0:15 2:33 0:10* 1:18 0:05 0:87 0:08†
Tissue mRNA levels were analyzed in duplicate per mouse (n 6 mice/feeding
group/genotype).
Values were normalized to 18S and expressed as meanSEM.
*P<0.05 HF vs. RD per genotype.
†P<0.05 L-CC1 vs. WT per feeding group.
FIGURE 1 |Western analysis of proteins involved in hepatic lipid
homeostasis. (A) Liver lysates from wild-type mice fed a regular (RD) or a
high-fat diet (HF) for 4months were analyzed by immunoblotting with α-Fasn
and α-CD36 antibodies, followed by reprobing with α-actin for normalization.
A representative gel of three different experiments performed on two mice per
feeding group is included. (B) Plasma from both WT and L-CC1 mice was
diluted and analyzed by 4–10% gradient SDS-PAGE and immunoblotting with
an antibody against apolipoprotein B (ApoB), which recognizes both ApoB48
and ApoB100. A representative gel of two independent experiments
performed on two different pairs of mice per feeding group per genotype is
included.
TABLE 4 | Effect of 4months of high-fat diet on mRNA of genes in white
adipose tissue.
WT L-CC1
RD HF RD HF
Fatp-4 0:80 0:10 1:80 0:22* 0:96 0:24 0:55 0:11†
Lpl 1:20 0:21 3:51 0:30* 1:12 0:12 1:25 0:40†
Srebp-1c 1:09 0:13 4:03 0:70* 1:26 0:51 0:94 0:32†
Hsl 0:49 0:10 0:80 0:11* 0:51 0:13 0:27 0:14†
F4/80 8:85 4:50 21:8 2:61* 5:45 1:22 9:08 3:01*†
TNFα 2:75 1:37 6:56 0:78* 3:55 0:78 3:01 1:05†
Smad7 11:3 2:56 1:72 0:40* 15:2 2:05 9:40 2:04†
Col6α3 0:67 0:11 1:58 0:25* 0:58 0:17 0:48 0:13†
α-Sma 0:03 0:01 1:05 0:33* 0:06 0:01 0:19 0:05†
Mice (n>5 per feeding group per genotype) were fed an HF diet for 4months starting at
2months of age.
Tissue mRNA levels were analyzed in duplicate per each mouse and normalized to 18S.
Values are expressed as meanSEM.
*P< 0.05 HF vs. RD per genotype.
†P< 0.05 L-CC1 vs. WT per feeding group.
Increased Macrophage Recruitment to White
Adipose Tissue in Response to High-Fat Diet
Histological analysis of H&E stained sections from WAT showed
a significant expansion of adipocytes in both groups of mice in
response to 4months of HF intake, but to a lower extent in L-CC1
mice (Figure 3).
Moreover, immunofluorescence analysis of F4/80, a
macrophage marker, showed multiple crown-like structures
(CLS) containing macrophages in WAT from HF-fed WT mice
(Figures 4A,A’, green). As previously shown (14), moving
through the individual z-stack sections shows numerous small
pieces of lipid inside the macrophages in CLS (Figures 4A,A’),
indicating adipocyte degradation inHF-fedWTmice. In contrast,
HF-fed L-CC1 mice exhibited minimal CLS formation with little
evidence of lipids inside the macrophages in these structures.
Consistently, HF diet-induced F4/80 mRNA levels by ~2.5-fold
in WT as compared to ~1.5-fold in WAT of L-CC1 mice, and
mRNA levels of TNFα adipokine in WT mice (by ~2-fold), but
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A
B
FIGURE 2 | Time-dependent effect of high-fat diet on fat distribution.
(A) Mice (n>10 mice/feeding group/genotype) were fed a regular (RD) or a
high-fat (HF) diet and their body weight (grams) was weighed for 0–24weeks.
Values expressed as meanSEM. *P<0.05 HF vs. RD and
†P<0.05 L-CC1 vs. WT per feeding group. (B) Whole body fat mass was
determined using NMR and expressed as percentage of total body weight
(n>10 mice/feeding group/genotype). Values expressed as meanSEM.
*P<0.05 HF vs. RD, †P<0.05 L-CC1 vs. WT per feeding group and
§P<0.05 HF-fed L-CC1 vs. RD-fed WT mice.
FIGURE 3 | Histological analysis of white adipose tissue. White adipose
tissue histology was assessed in H&E stained sections (n>4 mice/feeding
group/genotype). Lipid droplets indicate adipocytes’ expansion in response to
high-fat (HF) relative to regular diet (RD) in both genotypes. Of note, the
expansion in L-CC1 was relatively weaker than in WT mice. Representative
images from three sections per mouse are shown.
not in L-CC1 mice (Table 4). Together, this demonstrates that
protecting hepatic CEACAM1 levels against HF diet limited the
development of inflammation in the WAT of L-CC1 mice.
Induction of Fibrosis and TGF-β Activation in
White Adipose Tissue by High-Fat Diet
In agreement with reports showing TNFα inhibition of the
expression of Smad 7 (15), a negative regulator of TGF-
β–Smad2/3 signaling pathway (16, 17), HF markedly repressed
FIGURE 4 | Immunofluorescence analysis of white adipose tissue.
Whole white adipose tissue from HF-fed WT and L-CC1 mice was stained
with BODIPY 558/568 to detect lipid (gray) and with anti-F4/80 to detect
macrophages (green). All images were captured using LSCM with a 20
objective and are 2D projections of a 3D image z-stack. (A) Representative
picture from HF-fed WT mice. Yellow arrows show multiple areas with
crown-like structures (CLS). (A’). A blow up of the area around the bottom left
yellow arrow in (A) showing multiple layers of CLS containing macrophages
(green) surrounding adipocytes (gray). Also visible are small pieces of lipid
inside the macrophages. (B) Representative projection from HF-fed L-CC1
mice. One yellow arrow points out the single CLS detected in the image. (B’).
A blow up of the single CLS in (B) (yellow arrow) surrounding one adipocyte
from HF-fed L-CC1 mice. No small pieces of lipid are visible inside of
macrophages. Representative images from three sections per mouse are
shown.
(by ~5-fold) the mRNA level of Smad 7 in WT, but not L-CC1
mice (Table 4). Subsequently, HF induced Smad 2 and Smad 3
activation in the WAT of WT, but not L-CC1 mice, as assessed
by Western analysis of Smad 2 and Smad 3 phosphorylation
(Figure 5A).
In adipose tissue derived from WT, but not L-CC1 mice, HF
induced significantly the transcript levels of two main players in
fibrosis (Table 4): α-smooth muscle actin (α-Sma) (by10-fold)
and endotrophin/Col6α3 (by ~2-fold), a protein that promotes
metabolic derangement and fibrosis in adipose tissue (18). This
translated into a higher induction of collagen deposition in the
WAT of WT than L-CC1 mice by HF feeding, as shown by
trichrome staining (Figure 5B).
Discussion
Phenocopying L-SACC1 mice with liver-specific inactivation of
CEACAM1 and global Cc1 /  null mice (1–3), HF diet represses
hepatic CEACAM1 levels to impair insulin clearance and cause
hyperinsulinemia, which in turn, activates de novo lipogenic
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FIGURE 5 | Fibrosis in white adipose tissue. (A) Lysates from white
adipose tissue of wild-type (WT) and L-CC1 mice fed a regular (RD) or a
high-fat diet (HF) for 4months were analyzed by immunoblotting with
α-phospho-Smad 2 and phospho-Smad 3 antibodies followed by
reimmunoprobing (reIb) with antibodies against total Smad 2 and 3,
respectively, for normalization. A representative gel of three experiments
performed on two different mice per feeding group is included. (B) White
adipose tissue from five mice/feeding group/genotype was analyzed by
trichrome staining to detect collagen deposition. Representative images from
three sections per mouse are shown.
pathways and elevates lipid production in liver (7). The current
studies show that this drives lipid output (manifested by a rise in
plasma ApoB100/ApoB48) and redistribution to WAT to provoke
visceral obesity. This is consistent with a positive correlation
between liver steatosis, hyperinsulinemia, and high plasma ApoB
levels in humans and rodents (19–23). For instance, mice with
conditional null mutation of the insulin receptor in liver exhibit
impairment of insulin clearance and hepatic insulin resistance
with elevated lipogenesis, and a rise in plasma ApoB100/ApoB48
levels in parallel to low plasma triacylglycerol levels and obe-
sity (24).
In support of the important role that reducing hepatic CEA-
CAM1 level plays in the pathogenesis of diet-induced metabolic
derangement, protecting hepatic CEACAM1 levels by means of
transgenic induction preserves insulin clearance and prevents
insulin resistance and hepatic steatosis in response to HF feed-
ing (7). The current studies show that it also causes a delay
in the progression of fat accumulation and limits the expan-
sion of adipocytes in response to HF diet. Together, this sup-
ports an important role for altered CEACAM1-dependent insulin
clearance pathways in the pathogenesis of diet-induced hepatic
steatosis and visceral obesity. These findings lend a mechanistic
underpinning for the marked reduction of hepatic CEACAM1
observed in insulin-resistant obese subjects (25).
Immunofluorescence analysis showed less recruitment of CLS-
containing macrophages to the WAT of L-CC1 and less adipocyte
degradation inside these macrophages compared to WT mice.
In addition to normal mRNA levels of TNFα, an adipokine that
blunts insulin action (26), this could explain the protected insulin
sensitivity along the liver-WAT axis (7).
In addition to inflammation (26), visceral obesity and insulin
resistance are associated with increased fibrosis and activation of
TGF-β signaling pathways inWAT in rodents (18, 27) andhumans
(28). Consistently, HF feeding induced more collagen deposition
and activation of the TGF-β–Smad 2/3 pathway (16, 17) in WT
than L-CC1 mice. This could prevent adipose tissue remodeling
and contribute to themoremetabolic derangement in HF-fedWT
mice (29).
In summary, the current studies demonstrate that gain-of-
function of CEACAM1 in liver restricts visceral obesity caused by
HF diet, and that this is mediated, at least in part, by reducing lipid
output from liver and limiting inflammation and fibrosis in WAT.
Togetherwith increased FGF21 production (7), this couldmediate
in part, preserved energy expenditure in L-CC1 mice (7, 28, 30).
Because CEACAM1protein is not produced to a significant extent
inWAT (12), preserving adipose tissue biology could be attributed
to extra-adipocytic factors caused by inducingCEACAM1 expres-
sion in liver. Although the underlying mechanisms are not fully
delineated, the current studies provide a proof-of-principle of the
importance of hepatic CEACAM1-dependent insulin clearance in
the regulation of visceral obesity, and adipose tissue inflammation
and fibrosis in response to HF diet.
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